MRV Engenharia e Participações (MRVE3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
19 May, 2026Executive summary
Achieved record pre-sales, with net pre-sales reaching BRL 5 billion and over BRL 1 billion pre-sold in June 2024, surpassing pre-pandemic levels.
Gross margin of new sales reached 34%, with reported gross margin at 26% in 2Q24.
Cancellations are near zero, and SG&A contribution has improved.
Subsidiaries Luggo and Urba are transitioning to asset-light models, with Luggo showing strong rental demand and Urba returning to profitability.
U.S. subsidiary Resia is focusing on operational discipline, asset recycling, and zero cash burn, but continues to generate losses and has high leverage.
Financial highlights
Net revenue for 2Q24 was BRL 2.09 billion, up 18.0% year-over-year; net pre-sales reached a record BRL 5 billion.
EBITDA doubled to BRL 286 million, up 19% sequentially and 18.6% year-over-year.
Adjusted profit attributable to shareholders was BRL 76 million, 41% higher than Q1 2024.
Cash generation was BRL 32 million in 1H24, with expectations of BRL 300–400 million in H2.
Net debt to equity improved to 41%, down from year-end 2023, and net debt/EBITDA LTM improved to 3.08x.
Outlook and guidance
Confident in meeting or exceeding full-year guidance for revenue, margin, and cash generation; 2024 guidance reaffirmed.
Gross margin expected to continue rising as legacy projects are replaced by higher-margin new projects.
Anticipates further reduction in pro soluto, targeting close to 11% by year-end.
Positive impact expected from upcoming adjustments to MCMV income brackets, expanding customer base.
1H24 net revenue reached BRL 3.9 billion, gross margin 26%, and cash generation BRL 32 million, in line with annual targets.
Latest events from MRV Engenharia e Participações
- Record margins, strong sales, and US asset divestment drive outlook for further growth in 2026.MRVE3
Q4 202519 May 2026 - Revenue and launches surged, but cash flow was hit by transfer delays and US impairments.MRVE3
Q1 202519 May 2026 - Strong revenue growth, margin expansion, and deleveraging amid regulatory and operational tailwinds.MRVE3
Q3 202519 May 2026 - Margin expansion, operational excellence, and asset-light strategy drive future growth.MRVE3
Investor Day 202618 May 2026 - Net revenue rose 18% and adjusted net profit reached R$133 million, with robust cash generation.MRVE3
Q1 202614 May 2026 - Margin recovery, cost control, and capital optimization drive sustainable growth.MRVE3
Corporate presentation13 Apr 2026 - Record pre-sales and cash generation drive robust Q3 2024 performance and outlook.MRVE3
Q3 202414 Jan 2026 - Record sales, margin gains, and cash generation in 2024 set up strong 2025 growth and deleveraging.MRVE3
Q4 202417 Dec 2025 - Operational simplification, capital-light focus, and tech-driven efficiency set stage for record growth.MRVE3
Investor Day 202529 Nov 2025